Needham & Company
-
Myriad Genetics (MYGN) PT Raised to $37 at Needham & Company
-
Needham & Company Starts Myriad Genetics (MYGN) at Strong Buy
-
Pre-Open Stock Movers 02/08: (MYGN) (COHR) (MCHP) Higher; (GALE) (USNA) (EYES) Lower (more...)
-
Notable Analyst Rating Changes 12/03: (ABBV) (AAPL) (FRX) Upgraded; (PFE) (DIS) (AT) Downgraded
-
Streetinsider.com's Hot Lunchtime Reads 06/13: (MYGN) (CLSN) (DOLE) (PFE)
-
StreetInsider.com Pre-Open Movers 12/3: (SVU) (DECK) (DELL) Higher; (MYGN) (HMA) (RIMM) Lower (more...)
-
Notable Analyst Rating Changes 02/23: (AMAT) (AKS) (YOKU) (HOC) Upgraded; (NFLX) (FRX) (MDT) (MRO) Downgraded
-
Notable Analyst Rating Changes 05/13: MS, EBAY, S, MYGN, AUTH Upgraded; RAS, COF, SHPGY, JACK Downgraded
-
Notable Analyst Rating Changes 8/4: HBC, HGSI, PKY, DISH, TLB Upgraded; HOLX, ATML, ABX, STEC, LAMR Downgraded